Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal DNA synthesis enzyme" is a **non-specific term** that refers broadly to any enzyme involved in the process of synthesizing new strands of deoxyribonucleic acid in fungi. The most prominent class within this group is the **DNA polymerases**, such as **DNA polymerase delta** in yeast (*Saccharomyces cerevisiae*), which plays an essential role in chromosomal replication by catalyzing the addition of nucleotides during S-phase. This holoenzyme consists of multiple subunits with distinct roles in processivity and interaction with accessory proteins like PCNA (proliferating cell nuclear antigen)[4][6]. Other important enzymes include **topoisomerases**, which resolve supercoiling during replication and transcription by introducing transient breaks into the phosphate backbone of the double helix[7]. These enzymes are considered potential therapeutic targets because they are essential for fungal viability; however, most clinically used antifungals do not directly inhibit these targets due to concerns about selectivity over human homologs. Some research has focused on developing inhibitors specific for unique features found only in fungal versions of these enzymes. **Note:** The term "Fungal DNA synthesis enzyme" is too broad and non-canonical—it does not refer to a single well-defined molecular entity but rather encompasses several possible targets such as "Fungal DNA polymerase," "Fungal topoisomerase I," or "Fungal topoisomerase II." For structured data purposes, it is recommended to specify which particular enzyme is meant. > “DNA polymerase δ plays an essential role in replication from yeast to humans... comprised of three subunits... exhibits very high processivity...” [4] > “DNA ligation by ligases and strand extension by various classes of [polymerases] underpins all forms of nucleic acid metabolism.” [6] > “Research has revealed the genes responsible for encoding Topo I and II enzymes... at both gene sequence level and protein structure level.” [7] Because this entry lacks specificity regarding which exact protein/enzyme is intended—and because there are multiple distinct families involved—this target should be flagged as *incorrect* until clarified further.
Inhibition of enzymatic activity required for fungal genome replication leads to cell death or growth arrest[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal DNA polymerase.